Financial

The new money will be used for R&D, salaries and/or other compensation paid to executive officers in the ordinary course of business.

The new capital will go towards development of its the company's ICGM continuous glucose monitoring system for people with diabetes.

The company helps hospitals adapt to value-driven care by leveraging patient navigation to reduce risk, improve efficiency and increase competitiveness.

The figure represents nearly the total of all three prior years combined, representing a 125% year-on-year growth in funding compared to 2013.

The company makes a "smart bed" system which includes a touch-free sensor that measures heart and respiration rate, motion and bed-presence.

This latest funding will help get the two companies closer together, while ensuring that Ginger.io gets more widely used in hospitals.

The company makes an app that lets patients communicate with physicians via SMS; sent messages are responded in 24 hours or within 5 minutes for premium users.

The company's existing investors include WellPoint, Novartis, Dell and Coinstar, with Walter Huff joining in for this latest round.

The company plans to use the fresh capital to further develop its internet and marketing services, private exchange and customer service capabilities.

Metamorphic Ventures is joining existing investors Spark Capital and Soft Bank, while bringing the total seed round funds raised to $3.5 million.